Get the Stockscreener App
0.00
100.00%
-18.20
Reneo Pharmaceuticals Inc Stock (RPHM) Forecast
The Reneo Pharmaceuticals Inc (RPHM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.4776, representing a + increase from the current price of $0.00. The highest analyst price target is $2.5018, and the lowest is $0.4535.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RPHM Price Target
Average 2.9986
(+ Upside)
Is Reneo Pharmaceuticals Inc (RPHM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 18.64 | Buy |
| STOCH(9,6) | 72.39 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.6244 | Sell |
| ADX(14) | 25.30 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -444.37 | Sell |
Buy: 2
Sell: 4
Neutral: 1
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
14.83
Sell
|
13.52
Sell
|
| MA20 |
14.52
Sell
|
14.30
Sell
|
| MA50 |
14.63
Sell
|
14.74
Sell
|
| MA100 |
15.37
Sell
|
16.46
Sell
|
| MA200 |
15.97
Sell
|
24.38
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RPHM could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 14 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on RPHM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 18.64 indicates that RPHM is oversold. This indicates that RPHM price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 72.39 indicates that RPHM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that RPHM is oversold. This suggests that RPHM price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.3 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -444.37 indicates that RPHM is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term RPHM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Reneo Pharmaceuticals Inc financial reports and earnings history, Reneo Pharmaceuticals Inc (RPHM) stock could reach $5.2246 by 2030, $29.06 by 2040 and $60.01 by 2050. See the projected annual prices until 2050 of the Reneo Pharmaceuticals Inc stock below:
- Reneo Pharmaceuticals Inc (RPHM) is expected to reach an average price of $33.29 in 2035, with a high prediction of $32.99 and a low estimate of $33.49. This indicates an $ rise from the last recorded price of $0.00.
- Reneo Pharmaceuticals Inc (RPHM) stock is projected to chart a bullish course in 2040, with an average price target of $28.80, representing an $ surge from its current level. The forecast ranges from a conservative $28.76 to a sky-high $29.06.
- Our analysts predict Reneo Pharmaceuticals Inc (RPHM) to jump by 2045, soaring from $10.86 to an average price of $10.83, potentially reaching $11.59. While $10.86 is the low estimate, the potential upside is significant.
- Reneo Pharmaceuticals Inc (RPHM) stock is expected to climb by 2050, reaching an average of $58.64, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $60.01 and $58.86, respectively, highlighting the market's uncertainty.
Reneo Pharmaceuticals Inc Stock (RPHM) Year by Year Forecast
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2025
Reneo Pharmaceuticals Inc Stock (RPHM) is expected to reach an average price of $2.9986 in 2025, with a high prediction of $5.5437 and a low estimate of $0.4535. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $2.6018 | $0.4535 | $2.5018 | + |
| April, 2025 | $3.7225 | $3.438 | $3.4525 | + |
| May, 2025 | $4.927 | $4.4086 | $4.387 | + |
| June, 2025 | $5.5315 | $5.2491 | $5.1715 | + |
| July, 2025 | $5.8421 | $5.8476 | $5.5437 | + |
| August, 2025 | $5.2566 | $5.4766 | $5.4882 | + |
| September, 2025 | $4.7611 | $4.8011 | $5.1327 | + |
| October, 2025 | $4.5018 | $4.2056 | $4.2073 | + |
| November, 2025 | $3.7763 | $3.7301 | $4.2022 | + |
| December, 2025 | $3.3069 | $2.9236 | $3.2724 | + |
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2026
The predicted value for Reneo Pharmaceuticals Inc (RPHM) in 2026 is set at an average of $3.2877. Estimates vary from a peak of $6.4159 to a trough of $0.1594, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.2114 | $3.5253 | $3.1114 | + |
| February, 2026 | $3.7873 | $3.2075 | $3.3759 | + |
| March, 2026 | $4.2104 | $3.9643 | $3.6805 | + |
| April, 2026 | $3.1411 | $3.2711 | $3.5427 | + |
| May, 2026 | $2.6156 | $2.9456 | $2.9572 | + |
| June, 2026 | $2.2701 | $2.397 | $2.3178 | + |
| July, 2026 | $0.9393 | $0.1594 | $1.6154 | + |
| August, 2026 | $5.3948 | $0.2633 | $6.4159 | + |
| September, 2026 | $3.4442 | $2.5425 | $6.2087 | + |
| October, 2026 | $2.7096 | $2.0258 | $5.0019 | + |
| November, 2026 | $2.5951 | $1.5885 | $3.5313 | + |
| December, 2026 | $1.8645 | $1.2245 | $4.4629 | + |
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Reneo Pharmaceuticals Inc (RPHM) is $6.159, with a high forecast of $12.29 and a low forecast of $0.0267. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.47 | $1.8784 | $3.96 | + |
| February, 2027 | $4.8355 | $3.0239 | $5.0616 | + |
| March, 2027 | $4.6449 | $3.8295 | $5.8394 | + |
| April, 2027 | $3.4004 | $2.7765 | $4.7686 | + |
| May, 2027 | $1.3642 | $1.4042 | $4.982 | + |
| June, 2027 | $0.8048 | $0.8849 | $0.9703 | + |
| July, 2027 | $0.5893 | $0.5993 | $0.6909 | + |
| August, 2027 | $0.3638 | $0.4138 | $0.5254 | + |
| September, 2027 | $0.0244 | $0.0844 | $0.2999 | + |
| October, 2027 | $0.1289 | $0.0267 | $0.2311 | + |
| November, 2027 | $7.3268 | $8.3968 | $9.35 | + |
| December, 2027 | $9.718 | $12.28 | $12.29 | + |
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2028
In 2028, Reneo Pharmaceuticals Inc (RPHM) is projected to reach an average price of $11.40, with a high projection of $13.37 and a low estimate of $9.4269. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $12.00 | $12.20 | $11.59 | + |
| February, 2028 | $12.67 | $12.63 | $11.84 | + |
| March, 2028 | $9.2473 | $12.53 | $12.09 | + |
| April, 2028 | $11.25 | $11.80 | $10.90 | + |
| May, 2028 | $12.67 | $12.72 | $12.36 | + |
| June, 2028 | $10.93 | $11.37 | $12.07 | + |
| July, 2028 | $11.80 | $11.90 | $11.61 | + |
| August, 2028 | $8.9669 | $9.4269 | $9.5679 | + |
| September, 2028 | $11.79 | $10.34 | $11.31 | + |
| October, 2028 | $12.26 | $12.45 | $11.99 | + |
| November, 2028 | $13.61 | $12.90 | $12.95 | + |
| December, 2028 | $13.81 | $13.47 | $13.37 | + |
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2029
The 2029 price forecast for Reneo Pharmaceuticals Inc Stock (RPHM) is $10.48 on average, with a high prediction of $13.55 and a low estimate of $7.4224. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.50 | $13.65 | $13.55 | + |
| February, 2029 | $13.07 | $13.10 | $13.21 | + |
| March, 2029 | $11.64 | $12.16 | $12.48 | + |
| April, 2029 | $11.64 | $11.40 | $11.49 | + |
| May, 2029 | $10.45 | $10.58 | $11.29 | + |
| June, 2029 | $9.9638 | $9.6883 | $9.7127 | + |
| July, 2029 | $9.6528 | $10.02 | $9.5692 | + |
| August, 2029 | $9.9941 | $9.5951 | $9.7441 | + |
| September, 2029 | $9.6631 | $10.03 | $9.7563 | + |
| October, 2029 | $8.9344 | $9.0121 | $9.4454 | + |
| November, 2029 | $7.9334 | $8.2134 | $8.5116 | + |
| December, 2029 | $6.3124 | $7.4224 | $7.7356 | + |
Reneo Pharmaceuticals Inc Stock (RPHM) Price Forecast for 2030
Reneo Pharmaceuticals Inc Stock (RPHM) is expected to reach an average price of $2.627 in 2030, with a high forecast of $5.2246 and a low forecast of $0.0293. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.3737 | $4.7236 | $5.2246 | + |
| February, 2030 | $0.5027 | $0.7804 | $2.2159 | + |
| March, 2030 | $1.1117 | $1.3117 | $0.9741 | + |
| April, 2030 | $1.6307 | $0.7662 | $0.5538 | + |
| May, 2030 | $0.242 | $1.6675 | $1.247 | + |
| June, 2030 | $1.991 | $0.1342 | $1.401 | + |
| July, 2030 | $0.1577 | $0.5623 | $1.0132 | + |
| August, 2030 | $0.6687 | $0.1145 | $2.4687 | + |
| September, 2030 | $1.4897 | $0.7965 | $2.0365 | + |
| October, 2030 | $0.7785 | $0.0293 | $1.6674 | + |
| November, 2030 | $3.7406 | $0.975 | $3.9683 | + |
| December, 2030 | $3.2596 | $3.3397 | $3.5228 | + |
4.02%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):